Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 298-303 , September 2006

Six year incidence and progression of diabetic retinopathy: Results from the Mauritius diabetes complication study

  • Robyn J. Tapp

      Affiliations

    • Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    • International Diabetes Institute, Melbourne, Australia
    • Corresponding Author InformationCorresponding author at: Department of Epidemiology and Preventive Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Vic. 3004, Australia. Tel.: +61 9903 0542; fax: +61 9903 0576.
    • ,
  • Paul Z. Zimmet

      Affiliations

    • International Diabetes Institute, Melbourne, Australia
    • ,
  • C. Alex Harper

      Affiliations

    • Centre for Eye Research Australia, The University of Melbourne, Australia
    • ,
  • Daniel J. McCarty

      Affiliations

    • International Diabetes Institute, Melbourne, Australia
    • ,
  • Pierrot Chitson

      Affiliations

    • Ministry of Health and Quality of Life, Mauritius
    • ,
  • Andrew M. Tonkin

      Affiliations

    • Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    • ,
  • Stefan Söderberg

      Affiliations

    • International Diabetes Institute, Melbourne, Australia
    • ,
  • Hugh R. Taylor

      Affiliations

    • Centre for Eye Research Australia, The University of Melbourne, Australia
    • ,
  • K.G.M.M. Alberti

      Affiliations

    • Department of Medicine, University of Newcastle, Newcastle upon Tyne, UK
    • ,
  • Jaakko Tuomilehto

      Affiliations

    • Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland
    • ,
  • Jonathan E. Shaw

      Affiliations

    • International Diabetes Institute, Melbourne, Australia

Received 13 June 2005 ,Revised 13 December 2005 ,Accepted 8 February 2006.

References 

  1. Mensah E, Kohner E. Diagnosis and management of diabetic retinopathy. Topical Endocrinol. 2002;14–18
  2. Porta M, Bandello F. Diabetic retinopathy: a clinical update. Diabetologia. 2002;45:1617–1634
  3. Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in pima indians. Diabetes Care. 2003;26:320–326
  4. Leske MC, Wu SY, Hennis A, Nemesure B, Hyman L, Schachat A . Incidence of diabetic retinopathy in the Barbados Eye Studies. Ophthalmology. 2003;110:941–947
  5. McCarty DJ, Fu CL, Harper CA, Taylor HR, McCarty CA. Five-year incidence of diabetic retinopathy in the Melbourne visual impairment project. Clin. Exp. Ophthalmol. 2003;31:397–402
  6. van Leiden HA, Dekker JM, Moll AC, et al. Risk factors for incident retinopathy in a diabetic and non-diabetic population: the Hoorn study. Arch. Ophthalmol. 2003;121:245–251
  7. Janghorbani M, Amini M, Ghanbari H, Safaiee H. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran. Ophthalmic Epidemiol. 2003;10:81–95
  8. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch. Internal Med. 1994;154:2169–2178
  9. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N. Engl. J. Med. 329 (1993) 977–986.
  10. UK prospective diabetes study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet 352 (1998) 837–853.
  11. Klein BE, Moss SE, Klein R, Surawicz TS . The Wisconsin epidemiologic study of diabetic retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology. 1991;98:1261–1265
  12. Klein BE, Klein R, Moss SE, Palta M. A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch. Ophthalmol. 1995;113:601–606
  13. Ferris FL. How effective are treatments for diabetic retinopathy?. JAMA. 1993;269:1290–1291
  14. Agardh E, Agardh CD, Hansson-Lundblad C. The 5-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet. Med. 1993;10:555–559
  15. Dowse GK, Humphrey ARG, Collins VR, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am. J. Epidemiol. 1998;147:448–457
  16. Soderberg S, Zimmet P, Tuomilehto J, et al. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius. J. Int. Med. 2004;
  17. World Health Organisation: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, Department of Non-communicable Disease Surveillance, 1999.
  18. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK. Methodology for retinal photography and assessment of diabetic retinopathy: EURODIAB IDDM complications study. Diabetologia. 1995;38:437–444
  19. Younis N, Broadbent D, JPVora , Harding S. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool diabetic eye study: a cohort study. Lancet. 2003;361:195–200
  20. Stratton I, Kohner E, Aldington S, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type 2 diabetes over 6 years from diagnosis. Diabetologia. 2001;44:156–163
  21. Tudor S, Hamman R, Baron A, Johnson D, Shetterly S. Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. Diabetes Care. 1998;21:53–61
  22. Cohen O, Norymberg K, Neumann E, Dekel H. Complication-free duration and the risk of development of retinopathy in elderly diabetic patients. Arch. Intern. Med. 1998;158:641–644
  23. Klein R, Klein B, Moss S. The Wisconsin epidemiological study of diabetic retinopathy. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 or more years. Arch. Ophthalmol. 1989;1989:244–249
  24. Chen MS, Kao CS, Fu CC, Chen CJ, Tai TY. Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up. Int. J. Epidemiol. 1995;24:787–795
  25. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44:156–163
  26. Moss SE, Klein R, Klein BE . Cigarette smoking and 10-year progression of diabetic retinopathy. Ophthalmology. 1996;103:1438–1442
  27. Yoshida Y, Hagura R, Hara Y, Sugasawa G, Akanuma Y. Risk factors for the development of diabetic retinopathy in Japanese type 2 diabetic patients. Diabetes Res. Clin. Practice. 2001;51:195–203
  28. UK prospective diabetes study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38, Brit. Med. J. 317 (1998) 703–713.

PII: S0168-8227(06)00061-1

doi: 10.1016/j.diabres.2006.02.009

Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 298-303 , September 2006

Article Tools

* Image Usage & Resolution